Compare Novavax Inc (NVAX) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Vale SA — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Vale SA trades at $14.13 (market cap $59.07B). The key difference: Vale SA is far larger — about 45.4× Novavax Inc's market cap, and Vale SA pays a 8.93% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | VALE | |
|---|---|---|
Market Cap | $1.30B | $59.07B |
Sector | Health | Basic Materials |
52-Week High | $11.19 | $17.82 |
52-Week Low | $6.22 | $9.53 |
Enterprise Value | $800.50M | $75.99B |
Dividend Yield | — | 8.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
